Logo image of STKL

SUNOPTA INC (STKL) Stock Fundamental Analysis

NASDAQ:STKL - Nasdaq - CA8676EP1086 - Common Stock - Currency: USD

6.98  -0.07 (-0.99%)

After market: 6.98 0 (0%)

Fundamental Rating

3

STKL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. There are concerns on the financial health of STKL while its profitability can be described as average. STKL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

STKL had positive earnings in the past year.
In the past year STKL had a positive cash flow from operations.
STKL had negative earnings in 4 of the past 5 years.
Of the past 5 years STKL 4 years had a positive operating cash flow.
STKL Yearly Net Income VS EBIT VS OCF VS FCFSTKL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

1.2 Ratios

STKL has a worse Return On Assets (-2.91%) than 72.62% of its industry peers.
STKL has a worse Return On Equity (-11.53%) than 73.81% of its industry peers.
STKL has a Return On Invested Capital of 7.33%. This is in the better half of the industry: STKL outperforms 70.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STKL is below the industry average of 9.13%.
The 3 year average ROIC (4.60%) for STKL is below the current ROIC(7.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.91%
ROE -11.53%
ROIC 7.33%
ROA(3y)-9.36%
ROA(5y)-3.51%
ROE(3y)-34.91%
ROE(5y)-17.74%
ROIC(3y)4.6%
ROIC(5y)N/A
STKL Yearly ROA, ROE, ROICSTKL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

1.3 Margins

STKL has a Operating Margin of 7.18%. This is in the better half of the industry: STKL outperforms 65.48% of its industry peers.
In the last couple of years the Operating Margin of STKL has grown nicely.
STKL's Gross Margin of 18.78% is in line compared to the rest of the industry. STKL outperforms 45.24% of its industry peers.
In the last couple of years the Gross Margin of STKL has grown nicely.
Industry RankSector Rank
OM 7.18%
PM (TTM) N/A
GM 18.78%
OM growth 3Y68.62%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.9%
GM growth 5Y15.71%
STKL Yearly Profit, Operating, Gross MarginsSTKL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), STKL is destroying value.
STKL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, STKL has more shares outstanding
Compared to 1 year ago, STKL has a worse debt to assets ratio.
STKL Yearly Shares OutstandingSTKL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
STKL Yearly Total Debt VS Total AssetsSTKL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that STKL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.59, STKL is doing worse than 61.90% of the companies in the same industry.
STKL has a Debt/Equity ratio of 1.55. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.55, STKL is not doing good in the industry: 84.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACC0.88
WACC8.38%
STKL Yearly LT Debt VS Equity VS FCFSTKL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

STKL has a Current Ratio of 1.20. This is a normal value and indicates that STKL is financially healthy and should not expect problems in meeting its short term obligations.
STKL has a worse Current ratio (1.20) than 66.67% of its industry peers.
A Quick Ratio of 0.53 indicates that STKL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.53, STKL is doing worse than 77.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.53
STKL Yearly Current Assets VS Current LiabilitesSTKL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 175.00% over the past year.
STKL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.22%.
Measured over the past years, STKL shows a decrease in Revenue. The Revenue has been decreasing by -4.27% on average per year.
EPS 1Y (TTM)175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.17%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y-7.22%
Revenue growth 5Y-4.27%
Sales Q2Q%15.52%

3.2 Future

The Earnings Per Share is expected to grow by 83.16% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.81% on average over the next years. This is quite good.
EPS Next Y65.93%
EPS Next 2Y83.16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.4%
Revenue Next 2Y12.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STKL Yearly Revenue VS EstimatesSTKL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
STKL Yearly EPS VS EstimatesSTKL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4

2

4. Valuation

4.1 Price/Earnings Ratio

STKL is valuated quite expensively with a Price/Earnings ratio of 63.45.
STKL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.62. STKL is valued rather expensively when compared to this.
STKL is valuated quite expensively with a Price/Forward Earnings ratio of 29.72.
STKL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. STKL is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 63.45
Fwd PE 29.72
STKL Price Earnings VS Forward Price EarningsSTKL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as STKL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13
STKL Per share dataSTKL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

STKL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
STKL's earnings are expected to grow with 83.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y83.16%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

STKL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUNOPTA INC

NASDAQ:STKL (2/21/2025, 8:00:01 PM)

After market: 6.98 0 (0%)

6.98

-0.07 (-0.99%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners85.43%
Inst Owner Change-95.16%
Ins Owners1.73%
Ins Owner Change-0.15%
Market Cap835.16M
Analysts80
Price TargetN/A
Short Float %3.87%
Short Ratio9.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP-2.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)440.04%
Min EPS beat(2)-11.99%
Max EPS beat(2)892.08%
EPS beat(4)2
Avg EPS beat(4)243.03%
Min EPS beat(4)-27.99%
Max EPS beat(4)892.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.55%
Min Revenue beat(2)0.57%
Max Revenue beat(2)6.53%
Revenue beat(4)4
Avg Revenue beat(4)4.98%
Min Revenue beat(4)0.57%
Max Revenue beat(4)7.51%
Revenue beat(8)4
Avg Revenue beat(8)-2.98%
Revenue beat(12)5
Avg Revenue beat(12)-11.62%
Revenue beat(16)6
Avg Revenue beat(16)-11.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-4.55%
EPS NQ rev (3m)-4.55%
EPS NY rev (1m)0%
EPS NY rev (3m)6.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 63.45
Fwd PE 29.72
P/S 1.17
P/FCF N/A
P/OCF 39.13
P/B 4.74
P/tB 5.51
EV/EBITDA 13
EPS(TTM)0.11
EY1.58%
EPS(NY)0.23
Fwd EY3.36%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.18
OCFY2.56%
SpS5.95
BVpS1.47
TBVpS1.27
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -11.53%
ROCE 9.51%
ROIC 7.33%
ROICexc 7.37%
ROICexgc 7.72%
OM 7.18%
PM (TTM) N/A
GM 18.78%
FCFM N/A
ROA(3y)-9.36%
ROA(5y)-3.51%
ROE(3y)-34.91%
ROE(5y)-17.74%
ROIC(3y)4.6%
ROIC(5y)N/A
ROICexc(3y)4.61%
ROICexc(5y)N/A
ROICexgc(3y)5.31%
ROICexgc(5y)N/A
ROCE(3y)5.94%
ROCE(5y)N/A
ROICexcg growth 3Y33.04%
ROICexcg growth 5YN/A
ROICexc growth 3Y47.79%
ROICexc growth 5YN/A
OM growth 3Y68.62%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.9%
GM growth 5Y15.71%
F-Score5
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF N/A
Debt/EBITDA 3.16
Cap/Depr 90%
Cap/Sales 4.45%
Interest Coverage 250
Cash Conversion 24.73%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 0.53
Altman-Z 1.59
F-Score5
WACC8.38%
ROIC/WACC0.88
Cap/Depr(3y)219.46%
Cap/Depr(5y)167.3%
Cap/Sales(3y)9.42%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.17%
EPS Next Y65.93%
EPS Next 2Y83.16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.22%
Revenue growth 3Y-7.22%
Revenue growth 5Y-4.27%
Sales Q2Q%15.52%
Revenue Next Year16.4%
Revenue Next 2Y12.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.37%
EBIT growth 3Y56.44%
EBIT growth 5YN/A
EBIT Next Year181.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.52%
OCF growth 3Y-42.73%
OCF growth 5YN/A